ArticleFrontiers in cellular and infection microbiology2025
Tinea capitis in Hainan: a prospective study.
Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Tinea capitis, a chronic inflammatory disease of the scalp and hair shafts caused by dermatophyte infections, manifests clinically as erythematous lesions, scaling, alopecia, and pustule formation. Hainan, a tropical island province in China, exhibits distinctive climatic conditions and demographic contact patterns that could shape its pathogen spectrum. However, comprehensive epidemiological data remain scarce. This study analyzes the epidemiological characteristics and pathogen spectrum of tinea capitis in Hainan, China. Methods: This study was undertaken across 11 coastal and inland dermatological centers in Hainan Province (January 2023 to December 2024). A total of 76 tinea capitis patients diagnosed via mycological examination (fungal fluorescence microscopy, fungal culture with species identification) and corroborated by dermatoscopic evaluation were consecutively enrolled. Data on demographic characteristics, exposure history, and clinical manifestations were systematically collated using standardized case report forms. Pathogen subtyping was performed via integrated morphological identification supplemented by molecular biological analysis of the ITS region. Results: Among 76 enrolled patients, minors (≤15 years) accounted for 80.26% (61/76), with ≤10-year-olds representing 91.8% (56/61) of pediatric cases. The overall male-to-female ratio was recorded as 1:1.05 (37 males vs. 39 females), while pediatric patients (≤15 years) exhibited a 1.07:1 ratio (31 males vs. 29 females). Animal contact history was reported in 31 cases (40.79%), scalp trauma in 3 cases (3.95%), and co-occurring superficial fungal infections in 12 cases (15.79%). Fungal elements were detected via direct microscopic examination in 64 cases (84.21%). Fungal cultures obtained 45 positive isolates (19 strains in 2023, 26 in 2024), with kerion (inflammatory tinea capitis) exhibiting the highest culture positivity rate, followed by tinea alba. The primary pathogens identified were zoophilic Conclusion: The primary affected group is children ≤10 years old, with the most common pathogenic fungus being zoophilic
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.